Stonebridge Capital Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Stonebridge Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $3,402 - $4,134	5 Added 41.67%	17 $13,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1,411 - $1,532	2 Added 20.0%	12 $8,000
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1,190 - $1,396	-2 Reduced 16.67%	10 $7,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1,148 - $1,361	2 Added 20.0%	12 $7,000
Q2 2021 Aug 20, 2021	BUY	$472.8 - $558.54 $2,364 - $2,792	5 Added 100.0%	10 $6,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $2,233 - $2,741	5 New	5 $2,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.